Mason, OH, United States of America

Chinmay Maheshwari

This inventor holds 3 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Bausch + Lomb Ireland Limited, Novartis Ag. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chinmay Maheshwari. Retrieved from https://idiyas.com/inventor/chinmay-maheshwari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chinmay Maheshwari: Innovator in Ocular Treatments

Introduction

Chinmay Maheshwari is a notable inventor based in Mason, OH (US). He has made significant contributions to the field of ocular treatments, holding 3 patents that focus on innovative formulations for eye care.

Latest Patents

His latest patents include formulations of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile. This invention provides formulations aimed at treating ocular surface pain and offers methods for addressing dry eye disease and ocular hyperemia through the administration of these formulations.

Career Highlights

Chinmay has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Bausch + Lomb Ireland Limited. His experience in these organizations has contributed to his expertise in developing effective ocular treatments.

Collaborations

Chinmay has collaborated with notable coworkers such as Joseph Paul Bullock and Quintus Medley, enhancing his work through shared knowledge and expertise.

Conclusion

Chinmay Maheshwari's innovative work in ocular treatments showcases his dedication to improving eye care through scientific advancements. His contributions are significant in the realm of pharmaceuticals and continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…